- Home
- CG vs TEM Comparison
CG vs TEM Comparison
Compare CG & TEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CG
- TEM
- Stock Information
- Founded
- CG 1987
- TEM 2015
- Country
- CG United States
- TEM United States
- Employees
- CG N/A
- TEM N/A
- Industry
- CG Investment Managers
- TEM
- Sector
- CG Finance
- TEM
- Exchange
- CG Nasdaq
- TEM NYSE
- Market Cap
- CG 14.0B
- TEM 11.9B
- IPO Year
- CG 2012
- TEM 2024
- Fundamental
- Price
- CG $45.20
- TEM $55.18
- Analyst Decision
- CG Hold
- TEM Buy
- Analyst Count
- CG 15
- TEM 12
- Target Price
- CG $48.54
- TEM $63.90
- AVG Volume (30 Days)
- CG 2.8M
- TEM 17.4M
- Earning Date
- CG 05-08-2025
- TEM 05-06-2025
- Dividend Yield
- CG 3.10%
- TEM N/A
- EPS Growth
- CG N/A
- TEM N/A
- EPS
- CG 2.94
- TEM N/A
- Revenue
- CG $5,038,700,000.00
- TEM $803,315,000.00
- Revenue This Year
- CG N/A
- TEM $81.43
- Revenue Next Year
- CG $19.24
- TEM $24.96
- P/E Ratio
- CG $15.35
- TEM N/A
- Revenue Growth
- CG 127.13
- TEM 42.93
- 52 Week Low
- CG $33.02
- TEM $22.89
- 52 Week High
- CG $57.50
- TEM $91.45
- Technical
- Relative Strength Index (RSI)
- CG 56.17
- TEM N/A
- Support Level
- CG $43.19
- TEM N/A
- Resistance Level
- CG $46.44
- TEM N/A
- Average True Range (ATR)
- CG 1.42
- TEM 0.00
- MACD
- CG -0.07
- TEM 0.00
- Stochastic Oscillator
- CG 42.23
- TEM 0.00
About CG The Carlyle Group Inc.
The Carlyle Group is one of the world's largest alternative-asset managers, with $447.4 billion in total AUM, including $313.6 billion in fee-earning AUM, at the end of September 2024. The company has three core business segments: private equity, which includes private equity, real estate, infrastructure, and natural resources funds (accounting for 33% of fee-earning AUM and 57% of base management fees during 2023), global credit (51% and 27%) and investment solutions (16% and 16%). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving more than 2,900 active carry fund investors from 88 countries.
About TEM TEMPUS AI INC
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.